Managing 5FU Cardiotoxicity in Colorectal Cancer Treatment

Fluorouracil (5FU) is the backbone chemotherapy agent in the treatment of colorectal cancer (CRC). Cardiotoxicity represents an uncommon but serious side effect of treatment with 5FU. Here, we review the current literature on 5FU-cardiotoxicity in the setting of CRC specifically, with a focus on dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Anaka, Matthew, Abdel-Rahman, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799936/
https://www.ncbi.nlm.nih.gov/pubmed/35115827
http://dx.doi.org/10.2147/CMAR.S273544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799936/
https://www.ncbi.nlm.nih.gov/pubmed/35115827
http://dx.doi.org/10.2147/CMAR.S273544

Ejemplares similares